Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market - Global Outlook and Forecast 2024-2031

Report ID: 1377024 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Overall Market Size
    2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size: 2021 VS 2028
    2.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players in Global Market
    3.2 Top Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies Ranked by Revenue
    3.3 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Markets, 2021 & 2028
        4.1.2 Glassia
        4.1.3 Aralast NP
        4.1.4 Prolastin C
        4.1.5 Others
    4.2 By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue & Forecasts
        4.2.1 By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2022
        4.2.2 By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2023-2028
        4.2.3 By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Specialty Clinics
    5.2 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue & Forecasts
        5.2.1 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2022
        5.2.2 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2023-2028
        5.2.3 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2021 & 2028
    6.2 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue & Forecasts
        6.2.1 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2022
        6.2.2 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2023-2028
        6.2.3 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
        6.3.2 US Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.3.3 Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.3.4 Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
        6.4.2 Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.4.3 France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.4.4 U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.4.5 Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.4.6 Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.4.8 Benelux Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
        6.5.2 China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.5.3 Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.5.4 South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.5.6 India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
        6.6.2 Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.6.3 Argentina Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
        6.7.2 Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.7.3 Israel Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
        6.7.5 UAE Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 Grifols
        7.1.1 Grifols Corporate Summary
        7.1.2 Grifols Business Overview
        7.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
        7.1.4 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
        7.1.5 Grifols Key News
    7.2 CSL
        7.2.1 CSL Corporate Summary
        7.2.2 CSL Business Overview
        7.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
        7.2.4 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
        7.2.5 CSL Key News
    7.3 Baxter
        7.3.1 Baxter Corporate Summary
        7.3.2 Baxter Business Overview
        7.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
        7.3.4 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
        7.3.5 Baxter Key News
    7.4 Kamada
        7.4.1 Kamada Corporate Summary
        7.4.2 Kamada Business Overview
        7.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
        7.4.4 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
        7.4.5 Kamada Key News
    7.5 Takeda
        7.5.1 Takeda Corporate Summary
        7.5.2 Takeda Business Overview
        7.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
        7.5.4 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
        7.5.5 Takeda Key News
    7.6 Abeona
        7.6.1 Abeona Corporate Summary
        7.6.2 Abeona Business Overview
        7.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
        7.6.4 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
        7.6.5 Abeona Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Opportunities & Trends in Global Market
    Table 2. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers in Global Market
    Table 3. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints in Global Market
    Table 4. Key Players of Alpha-1 Antitrypsin Deficiency Augmentation Therapy in Global Market
    Table 5. Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Type
    Table 9. List of Global Tier 1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Grifols Corporate Summary
    Table 31. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
    Table 32. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. CSL Corporate Summary
    Table 34. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
    Table 35. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. Baxter Corporate Summary
    Table 37. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
    Table 38. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Kamada Corporate Summary
    Table 40. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
    Table 41. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Takeda Corporate Summary
    Table 43. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
    Table 44. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. Abeona Corporate Summary
    Table 46. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
    Table 47. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Segment by Type in 2021
    Figure 2. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Segment by Application in 2021
    Figure 3. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
    Figure 8. By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    Figure 12. US Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    Figure 24. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports